1. Academic Validation
  2. Pentafluorosulfanyl-substituted biaryl derivatives as MATE-type transporter inhibitors targeting drug-resistant bacteria

Pentafluorosulfanyl-substituted biaryl derivatives as MATE-type transporter inhibitors targeting drug-resistant bacteria

  • Bioorg Med Chem. 2024 Feb 1:99:117606. doi: 10.1016/j.bmc.2024.117606.
Susumu Shinya 1 Kentaro Kawai 2 Naoki Kobayashi 3 Yukiko Karuo 1 Atsushi Tarui 1 Kazuyuki Sato 1 Masato Otsuka 1 Masaaki Omote 1
Affiliations

Affiliations

  • 1 Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan.
  • 2 Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan. Electronic address: [email protected].
  • 3 Faculty of Agriculture, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan.
Abstract

Multidrug and toxin extrusion (MATE) inhibitors improve the antimicrobial susceptibility of drug-resistant bacteria by preventing the efflux of administered Antibiotics. In this study, we optimized the chemical structure of a previously identified bacterial-selective MATE inhibitor 1 (EC50 > 30 µM) to improve its activity further. Compound 1 was divided into three fragments (aromatic part, linker part, and guanidine part), and each part was individually optimized. Compound 31 (EC50 = 1.8 µM), a novel pentafluorosulfanyl-containing molecule synthesized following optimized parts, showed antimicrobial activity against MATE-expressing strains at concentrations lower than conventional inhibitor 1 when co-administrated with norfloxacin. Furthermore, 31 was not cytotoxic at effective concentrations. This suggests that compound 31 can be a promising candidate for combating Bacterial infections, particularly those resistant to conventional Antibiotics by MATE expression.

Keywords

Antimicrobials; Efflux pump inhibitor; Multidrug and toxic compound extrusion; Multidrug-resistant bacteria; Pentafluorosulfanyl.

Figures
Products